Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Orbimed Advisors LLC reported a 5.40% stake in Cytomx Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 14, 2025
Orbimed Advisors LLC reported a 5.40% stake in Cytomx Therapeutics, Inc., 8,461,500 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 8,461,500
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 5.40% | 8,461,500 |
Source
Related
- Cytomx Therapeutics, Inc.
- Orbimed Advisors LLC
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Feb 17, 2026
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026